Prevalence and Perceived Preventability of Self-Reported Adverse Drug Events – A Population-Based Survey of 7099 Adults

Purpose Adverse drug events (ADEs) are common and often preventable among inpatients, but self-reported ADEs have not been investigated in a representative sample of the general public. The objectives of this study were to estimate the 1-month prevalence of self-reported ADEs among the adult general public, and the perceived preventability of 2 ADE categories: adverse drug reactions (ADRs) and sub-therapeutic effects (STEs). Methods In this cross-sectional study, a postal survey was sent in October 2010 to a random sample of 13 931 Swedish residents aged ≥18 years. Self-reported ADEs experienced during the past month included ADRs, STEs, drug dependence, drug intoxications and morbidity due to drug-related untreated indication. ADEs could be associated with prescription, non-prescription or herbal drugs. The respondents estimated whether ADRs and STEs could have been prevented. ADE prevalences in age groups (18–44, 45–64, or ≥65 years) were compared. Results Of 7099 respondents (response rate 51.0%), ADEs were reported by 19.4% (95% confidence interval, 18.5–20.3%), and the prevalence did not differ by age group (p>0.05). The prevalences of self-reported ADRs, STEs, and morbidities due to drug-related untreated indications were 7.8% (7.2–8.4%), 7.6% (7.0–8.2%) and 8.1% (7.5–8.7%), respectively. The prevalence of self-reported drug dependence was 2.2% (1.9–2.6%), and drug intoxications 0.2% (0.1–0.3%). The respondents considered 19.2% (14.8–23.6%) of ADRs and STEs preventable. Although reported drugs varied between ADE categories, most ADEs were attributable to commonly dispensed drugs. Drugs reported for all and preventable events were similar. Conclusions One-fifth of the adult general public across age groups reported ADEs during the past month, indicating a need for prevention strategies beyond hospitalised patients. For this, the underlying causes of ADEs should increasingly be investigated. The high burden of ADEs and preventable ADEs from widely used drugs across care settings supports redesigning a safer healthcare system to adequately tackle the problem.

[1]  M. Petzold,et al.  Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey , 2013, BMJ Open.

[2]  M. Talbäck,et al.  Public health: An overview , 2012, Scandinavian journal of public health.

[3]  M. Petzold,et al.  Methods for Assessing the Preventability of Adverse Drug Events , 2012, Drug Safety.

[4]  I. Ralph Edwards.  Prevention and Pharmacovigilance , 2012, Drug Safety.

[5]  P. Barreto.  Participation bias in postal surveys among older adults: the role played by self-reported health, physical functional decline and frailty. , 2012, Archives of gerontology and geriatrics.

[6]  H. Gyllensten,et al.  Modelling drug-related morbidity in Sweden using an expert panel of pharmacists’ , 2012, International Journal of Clinical Pharmacy.

[7]  Max Petzold,et al.  Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis , 2012, PloS one.

[8]  H. Gyllensten,et al.  Modelling drug-related morbidity in Sweden using an expert panel of physicians , 2012, European Journal of Clinical Pharmacology.

[9]  David W. Bates,et al.  Errors associated with outpatient computerized prescribing systems , 2011, J. Am. Medical Informatics Assoc..

[10]  J. E. Doormaal,et al.  Preventable and Non-Preventable Adverse Drug Events in Hospitalized Patients , 2011, Drug safety.

[11]  P. Cuijpers.  The patient perspective in research on major depression , 2011, BMC psychiatry.

[12]  C M Bond,et al.  Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. , 2011, Health technology assessment.

[13]  R. Paster,et al.  Chronic pain management issues in the primary care setting and the utility of long-acting opioids , 2010 .

[14]  K. Farris,et al.  Concerns and beliefs about medicines and inappropriate medications: An Internet-based survey on risk factors for self-reported adverse drug events among older adults. , 2010, The American journal of geriatric pharmacotherapy.

[15]  C. Vincent.  Clinical Interventions and Process Improvement , 2010 .

[16]  Michael Green,et al.  Adverse events experienced by homecare patients: a scoping review of the literature. , 2010, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[17]  Ethan Basch,et al.  The missing voice of patients in drug-safety reporting. , 2010, The New England journal of medicine.

[18]  Akashdeep Singh.  Asthma in older adults , 2009, Canadian Medical Association Journal.

[19]  M. Pirmohamed,et al.  Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes , 2009, PloS one.

[20]  Yosef H. Al-Olah,et al.  Admissions through the emergency department due to drug-related problems , 2008, Annals of Saudi medicine.

[21]  J. Weissman,et al.  Comparing Patient-Reported Hospital Adverse Events with Medical Record Review: Do Patients Know Something That Hospitals Do Not? , 2008, Annals of Internal Medicine.

[22]  P. Noyce,et al.  Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies , 2008, The Annals of pharmacotherapy.

[23]  D. Isacson,et al.  Nationwide Survey of Subjectively Reported Adverse Drug Reactions in Sweden , 2008, The Annals of pharmacotherapy.

[24]  W. Doucette,et al.  Risk Factors for Self-Reported Adverse Drug Events Among Medicare Enrollees , 2008, The Annals of pharmacotherapy.

[25]  A. Melander,et al.  Systematic Review of the Incidence and Characteristics of Preventable Adverse Drug Events in Ambulatory Care , 2007, The Annals of pharmacotherapy.

[26]  Anders Sundström,et al.  The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months , 2007, Pharmacoepidemiology and drug safety.

[27]  Elizabeth L. Ogburn,et al.  Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. , 2007, Archives of general psychiatry.

[28]  A H Zargarzadeh,et al.  DRUG‐RELATED HOSPITAL ADMISSIONS IN A GENERIC PHARMACEUTICAL SYSTEM , 2007, Clinical and experimental pharmacology & physiology.

[29]  Jonathan N. Hawley,et al.  Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? , 2007, The American journal of geriatric pharmacotherapy.

[30]  M. Pirmohamed,et al.  Which drugs cause preventable admissions to hospital? A systematic review. , 2007, British journal of clinical pharmacology.

[31]  R. Wallace,et al.  Risk Factors for Adverse Drug Events in Older Adults with Mobility Limitations in the Community Setting , 2007, Journal of the American Geriatrics Society.

[32]  Joshua Borus,et al.  Patient-reported medication symptoms in primary care. , 2005, Archives of internal medicine.

[33]  D. Bates,et al.  Adverse drug events and medication errors: detection and classification methods , 2004, Quality and Safety in Health Care.

[34]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[35]  P. Kanjanarat,et al.  Nature of preventable adverse drug events in hospitals: a literature review. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[36]  K. Stewart,et al.  The ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you? , 2003, Supportive Care in Cancer.

[37]  Joshua Borus,et al.  Adverse drug events in ambulatory care. , 2003, The New England journal of medicine.

[38]  W B Runciman,et al.  Setting priorities for patient safety , 2002, Quality & safety in health care.

[39]  Emily S. Patterson,et al.  Research Paper: Improving Patient Safety by Identifying Side Effects from Introducing Bar Coding in Medication Administration , 2002, J. Am. Medical Informatics Assoc..

[40]  C. Poole,et al.  Preventable Drug-Related Hospital Admissions , 2002, The Annals of pharmacotherapy.

[41]  J. Millar,et al.  Consultations owing to adverse drug reactions in a single practice. , 2001, The British journal of general practice : the journal of the Royal College of General Practitioners.

[42]  I. Edwards,et al.  Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.

[43]  D W Bates,et al.  Incidence and preventability of adverse drug events in nursing homes. , 2000, The American journal of medicine.

[44]  T W Nolan,et al.  service Topic collections Notes , 2022 .

[45]  E. Cook,et al.  Drug complications in outpatients , 2000, Journal of general internal medicine.

[46]  D. Bates,et al.  Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. , 1999, Archives of internal medicine.

[47]  D. Bates,et al.  Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. , 1999, JAMA.

[48]  R. Raschetti,et al.  Suspected adverse drug events requiring emergency department visits or hospital admissions , 1999, European Journal of Clinical Pharmacology.

[49]  D. Bates,et al.  Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. , 1998, JAMA.

[50]  J Hasford,et al.  Adverse drug reaction monitoring—cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission , 1997, Pharmacoepidemiology and drug safety.

[51]  J. A. Johnson,et al.  Drug-Related Morbidity and Mortality: A Cost-of-Illness Model , 1995 .

[52]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[53]  R B Wallace,et al.  Self-Reported Adverse Drug Reactions and Related Resource Use , 1992, Annals of Internal Medicine.

[54]  J. Hallas,et al.  Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention , 1990, Journal of internal medicine.

[55]  J. Mckenney,et al.  Drug-related hospital admissions. , 1976, American journal of hospital pharmacy.

[56]  P. Bemt,et al.  This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. The Relationship Between Study Characteristics and the Prevalence of Medication-Related Hospitalizations A Literature Review and Novel Analysis , 2010 .

[57]  M. Griffin,et al.  Medication-Related Admissions in Older People , 2009, Drugs & aging.

[58]  Suely Rozenfeld,et al.  Adverse drug events in hospitals: a systematic review. , 2009, Cadernos de saude publica.

[59]  R. Koneri,et al.  Drug-Related Hospitalizations at a Tertiary Level Hospital in Bangalore: A Prospective Study , 2008 .

[60]  Anu MacIntosh-Murray,et al.  High Performing Healthcare Systems , 2008 .

[61]  B. Grant,et al.  Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. , 2007, Archives of general psychiatry.

[62]  Jeffrey K Aronson,et al.  Clarification of Terminology in Drug Safety , 2005, Drug safety.

[63]  Dieuwke G. Gijssel-Wiersma,et al.  Influence of Computerised Medication Charts on Medication Errors in a Hospital , 2005, Drug safety.

[64]  G. Bocci,et al.  Drug therapeutic failures in emergency department patients. A university hospital experience. , 2004, Pharmacological research.

[65]  R. Hu.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) , 2003 .

[66]  J. Edwards,et al.  Extra Adverse drug reactions in hospital patients A systematic review of the prospective and retrospective studies , 2002 .

[67]  Organización Mundial de la Salud.  Guidelines for ATC classification and DDD assignment , 1996 .

[68]  S D Small,et al.  Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. , 1995, JAMA.

[69]  J L Bootman,et al.  Drug-related morbidity and mortality. A cost-of-illness model. , 1995, Archives of internal medicine.

[70]  J. Hallas,et al.  Drug related admissions to medical wards: a population based survey. , 1992, British journal of clinical pharmacology.

[71]  放射線影響研究所.  Technical report series , 1989 .

[72]  M S Kramer,et al.  Frequency, severity and risk factors for adverse drug reactions in adult out-patients: a prospective study. , 1986, Journal of chronic diseases.

[73]  International drug monitoring: the role of national centres. Report of a WHO meeting. , 1972, World Health Organization technical report series.